Viewing Study NCT05756920


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
Study NCT ID: NCT05756920
Status: COMPLETED
Last Update Posted: 2025-07-23
First Post: 2023-01-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants
Sponsor: ABL Bio, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-12-31
Start Date Type: ACTUAL
Primary Completion Date: 2025-04-30
Primary Completion Date Type: ACTUAL
Completion Date: 2025-04-30
Completion Date Type: ACTUAL
First Submit Date: 2023-01-20
First Submit QC Date: None
Study First Post Date: 2023-03-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-20
Last Update Post Date: 2025-07-23
Last Update Post Date Type: ACTUAL